Regulation by post-translation modifications in response to stress

通过翻译后修饰来应对压力的调节

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Signaling pathways activated by stress or cellular cues modify existing proteins post-translationally by phosphorylation, acetylation and ubiquitination, in order to rapidly alter physiology. We will examine regulation through post-translational modifications (PTMs) in response to several forms of stress, paying special attention to alterations in phosphorylation and ubiquitination in response to DNA damage. Our examination of the ubiquitin pathway has two primary areas of focus: ubiquitin linkage analysis and substrate identification. Ubiquitin chains are formed on substrates using any of ubiquitin's seven lysines. We take a genetic approach in yeast to explore the significance of these chains by identifying mutants that have synthetic genetic interactions with ubiquitin lysine mutants unable to form particular chain types. To identify ubiquitin ligase substrates, we developed a method called Ligase Trapping, in which we fuse a poly-ubiquitin binding domain onto a ubiquitin ligase, which increases the affinity of the ligase with its ubiquitinated substrate, allowing substrate identification via mass spectroscopy. We have carried this out in both yeast and human cells, and will follow-up on several interesting hits. We are particularly interested in ubiquitin-mediated protein turnover in response to DNA damage. DNA damage-regulated protein turnover typically occurs after a substrate is phosphorylated by one of several checkpoint kinases. Checkpoint kinases, such as ATR, CHK1 and CHK2 are activated upon DNA damage and regulate a large number of pathways. We will continue our effort to identify substrates of the DNA damage checkpoint, focusing on targets involved in either cell cycle regulation or metabolism. As with our examination of ubiquitin ligase substrates, we will generate alleles that cannot be modified and examine their effects on cellular physiology. Finally, we have developed a method by which phosphatases, de-ubiquitinases, HDACs, or other enzymes can be localized individually to each protein in yeast. We will use this technology to identify modifications that are essential for viability either in unperturbed cells, or in respose to stresses such as DNA damage. Together with our substrate identification studies, this will allow us to generate a global, functional picture of protein modification.
 描述(由申请人提供):由应激或细胞信号激活的信号通路通过磷酸化、乙酰化和泛素化对现有蛋白质进行后期修饰,以快速改变生理学。我们将通过翻译后修饰(PTM)来研究对几种形式的应激的调节,特别注意对DNA损伤的磷酸化和泛素化的改变。我们对泛素途径的研究主要集中在两个方面:泛素连接分析和底物鉴定。泛素链是利用泛素的七个赖氨酸中的任何一个在底物上形成的。我们在酵母中采取遗传方法,通过鉴定与不能形成特定链类型的泛素赖氨酸突变体具有合成遗传相互作用的突变体来探索这些链的意义。为了识别泛素连接酶底物,我们开发了一种称为连接酶捕获的方法,在该方法中,我们将多聚泛素结合结构域融合到泛素连接酶上,这增加了连接酶与其泛素化底物的亲和力,从而允许通过质谱进行底物识别。我们已经在酵母和人类细胞中进行了这一研究,并将跟踪几个有趣的结果。我们特别感兴趣的是泛素介导的蛋白质周转在DNA损伤的反应。DNA损伤调节的蛋白质周转通常发生在底物被几种检查点激酶之一磷酸化之后。检查点激酶如ATR、CHK1和CHK2在DNA损伤时被激活并调节大量途径。我们将继续努力确定DNA损伤检查点的底物,重点关注参与细胞周期调控或代谢的靶点。正如我们对泛素连接酶底物的研究一样,我们将产生不能被修饰的等位基因,并研究它们对细胞生理学的影响。最后,我们开发了一种方法,通过该方法,磷酸酶、去泛素化酶、HDAC或其他酶可以单独定位于酵母中的每种蛋白质。我们将使用这种技术来识别在未受干扰的细胞中或在应对诸如DNA损伤等应激时对生存力至关重要的修饰。结合我们的底物鉴定研究,这将使我们能够生成蛋白质修饰的全局功能图。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Paul Toczyski其他文献

David Paul Toczyski的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Paul Toczyski', 18)}}的其他基金

Characterizing the role of RNF25 in repair of DNA alkylation in blood cancers
表征 RNF25 在血癌 DNA 烷基化修复中的作用
  • 批准号:
    10438061
  • 财政年份:
    2022
  • 资助金额:
    $ 69.67万
  • 项目类别:
Characterizing the role of RNF25 in repair of DNA alkylation in blood cancers
表征 RNF25 在血癌 DNA 烷基化修复中的作用
  • 批准号:
    10580070
  • 财政年份:
    2022
  • 资助金额:
    $ 69.67万
  • 项目类别:
Regulation by post-translation modifications in response to stress
通过翻译后修饰来应对压力的调节
  • 批准号:
    10098111
  • 财政年份:
    2016
  • 资助金额:
    $ 69.67万
  • 项目类别:
Regulation by post-translation modifications in response to stress
通过翻译后修饰来应对压力的调节
  • 批准号:
    10801759
  • 财政年份:
    2016
  • 资助金额:
    $ 69.67万
  • 项目类别:
Regulation by post-translation modifications in response to stress
通过翻译后修饰来应对压力的调节
  • 批准号:
    10609884
  • 财政年份:
    2016
  • 资助金额:
    $ 69.67万
  • 项目类别:
Regulation by post-translation modifications in response to stress
通过翻译后修饰来应对压力的调节
  • 批准号:
    10198226
  • 财政年份:
    2016
  • 资助金额:
    $ 69.67万
  • 项目类别:
Regulation by post-translation modifications in response to stress
通过翻译后修饰来应对压力的调节
  • 批准号:
    9071173
  • 财政年份:
    2016
  • 资助金额:
    $ 69.67万
  • 项目类别:
Regulation by post-translation modifications in response to stress
通过翻译后修饰来应对压力的调节
  • 批准号:
    10388393
  • 财政年份:
    2016
  • 资助金额:
    $ 69.67万
  • 项目类别:
Identifying the targets of oncogenic/tumor-suppressive F box proteins
鉴定致癌/肿瘤抑制 F 盒蛋白的靶标
  • 批准号:
    9016501
  • 财政年份:
    2015
  • 资助金额:
    $ 69.67万
  • 项目类别:
Cell cycle regulation by ubiquitin ligases
泛素连接酶的细胞周期调节
  • 批准号:
    7995625
  • 财政年份:
    2010
  • 资助金额:
    $ 69.67万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.67万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.67万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 69.67万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.67万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.67万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.67万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.67万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 69.67万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 69.67万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 69.67万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了